These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35804897)

  • 1. The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma.
    Chen L; Chiang YC; Chan LS; Chau WY; Lung ML; Kahn M; Lo KW; Mak NK; Lung HL
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
    Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
    Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.
    Ding Y; Pan Y; Liu S; Jiang F; Jiao J
    Cancer Biol Ther; 2017 Jun; 18(6):414-424. PubMed ID: 28613134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
    Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miR-96/EVI1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation.
    Chan LS; Lung HL; Ngan RK; Lee AW; Tsao SW; Lo KW; Kahn M; Lung ML; Wieser R; Mak NK
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression By Modulating miR-124-3p/ITGB1 Axis.
    Liu C; Zhang H; Liu H
    Onco Targets Ther; 2019; 12():8455-8466. PubMed ID: 31632090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
    Zhang J; Wen X; Ren XY; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Sun Y; Liu N; Ma J
    J Exp Clin Cancer Res; 2016 Jul; 35(1):109. PubMed ID: 27400785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y; Wang M; Li X; Cui F
    Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.
    Liu Y; Jiang Q; Liu X; Lin X; Tang Z; Liu C; Zhou J; Zhao M; Li X; Cheng Z; Li L; Xie Y; Liu Z; Fang W
    EBioMedicine; 2019 Oct; 48():386-404. PubMed ID: 31594754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling.
    Huang J; Qin Y; Yang C; Wan C; Dai X; Sun Y; Meng J; Lu Y; Li Y; Zhang Z; Wu B; Xu S; Jin H; Yang K
    Aging (Albany NY); 2020 Jan; 12(1):340-358. PubMed ID: 31907338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
    Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-384 inhibits nasopharyngeal carcinoma growth and metastasis via binding to Smad5 and suppressing the Wnt/β-catenin axis.
    Zeng X; Liao H; Wang F
    Cytotechnology; 2021 Apr; 73(2):203-215. PubMed ID: 33911345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.
    Sinnung S; Janvilisri T; Kiatwuthinon P
    Mol Cell Biochem; 2021 Apr; 476(4):1663-1672. PubMed ID: 33423190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.
    Zhang Y; Zhang H; Li X
    J BUON; 2020; 25(3):1579-1586. PubMed ID: 32862607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.